MicroRNAs may mediate the down-regulation of neurokinin-1 receptor in chronic bladder pain syndrome

American Journal of Pathology

Volumn 176, Issue 1, 2010, Pages 288-303

  Freire, Veronica Sanchez ^a   Burkhard, Fiona C ^b   Kessler, Thomas M ^b   Kuhn, Annette ^b   Draeger, Annette ^a   Monastyrskaya, Katia ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ B1 RECEPTOR; CANNABINOID 1 RECEPTOR; JUNCTIONAL ADHESION MOLECULE A; MESSENGER RNA; MICRORNA; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; OCCLUDIN; PROTEIN ZO1; SUBSTANCE P; TETRACYCLINE; VALACICLOVIR;

ADULT; AGED; AMINO ACID SYNTHESIS; ARTICLE; ATTENUATION; BLADDER BIOPSY; BLADDER CONTRACTION; BLADDER PAIN SYNDROME; CELL MEMBRANE PERMEABILITY; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTALGIA; CYSTITIS; DOWN REGULATION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; HYPOTHESIS; MALE; MOLECULAR MECHANICS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REGULATORY MECHANISM; UROTHELIUM;

EID: 73949159185     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090552     Document Type: Article

References (68)

1. van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, Elneil S, Fall M, Hohlbrugger G, Irwin P: Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 2008, 53:60-67
2. Curhan GC, Speizer FE, Hunter DJ, Curhan SG, Stampfer MJ: Epidemiology of interstitial cystitis: a population based study. J Urol 1999, 161:549-552
3. Fall M, Oberpenning F, Peeker R: Treatment of bladder pain syndrome/ interstitial cystitis: can we make evidence-based decisions? Eur Urol 2008, 54:65-75
4. Theoharides TC, Whitmore K, Stanford E, Moldwin R, O'Leary MP: Interstitial cystitis: bladder pain and beyond. Expert Opin Pharmacother 2008, 9:2979-2994
5. Lilly JD, Parsons CL: Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg Gynecol Obstet 1990, 171:493-496
6. Moskowitz MO, Byrne DS, Callahan HJ, Parsons CL, Valderrama E, Moldwin RM: Decreased expression of a glycoprotein component of bladder surface mucin (GP1) in interstitial cystitis. J Urol 1994, 151:343-345
7. Keay S: Cell signaling in interstitial cystitis/painful bladder syndrome. Cell Signal 2008, 20:2174-2179
8. Hohenfellner M, Nunes L, Schmidt RA, Lampel A, Thuroff JW, Tanagho EA: Interstitial cystitis: increased sympathetic innervation and related neuropeptide synthesis. J Urol 1992, 147:587-591
9. Pang X, Marchand J, Sant GR, Kream RM, Theoharides TC: Increased number of substance P positive nerve fibres in interstitial cystitis. Br J Urol 1995, 75:744-750
10. Kushner L, Chiu PY, Brettschneider N, Lipstein A, Eisenberg E, Rofeim O, Moldwin R: Urinary substance P concentration correlates with urinary frequency and urgency in interstitial cystitis patients treated with intravesical dimethyl sulfoxide and not intravesical anesthetic cocktail. Urology 2001, 57:129
11. Fraser CC: G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer. Int Rev Immunol 2008, 27:320-350
12. Saban R, Saban MR, Nguyen NB, Lu B, Gerard C, Gerard NP, Hammond TG: Neurokinin-1 (NK-1) receptor is required in antigen-induced cystitis. Am J Pathol 2000, 156:775-780
13. Quartara L, Maggi CA: The tachykinin NK1 receptor. Part II: distribution and pathophysiological roles. Neuropeptides 1998, 32:1-49
14. Meini S, Patacchini R, Maggi CA: Tachykinin NK1 receptor subtypes in the rat urinary bladder. Br J Pharmacol 1994, 111:739-746
15. Candenas L, Lecci A, Pinto FM, Patak E, Maggi CA, Pennefather JN: Tachykinins and tachykinin receptors: effects in the genitourinary tract. Life Sci 2005, 76:835-862
16. Marchand JE, Sant GR, Kream RM: Increased expression of substance P receptor-encoding mRNA in bladder biopsies from patients with interstitial cystitis. Br J Urol 1998, 81:224-228
17. Warner FJ, Miller RC, Burcher E: Human tachykinin NK2 receptor: a comparative study of the colon and urinary bladder. Clin Exp Pharmacol Physiol 2003, 30:632-639
18. Burcher E, Zeng XP, Strigas J, Shang F, Millard RJ, Moore KH: Autoradiographic localization of tachykinin and calcitonin gene-related peptide receptors in adult urinary bladder. J Urol 2000, 163:331-337
19. Ishizuka O, Mattiasson A, Andersson KE: Tachykinin effects on bladder activity in conscious normal rats. J Urol 1995, 154:257-261
20. Burkhard FC, Lemack GE, Alcorn MD, Zimmern PE, Lin VK, Connell JD: Up-regulation of a gene homologous to the human tumor necrosis factor receptor associated factor 6 gene in the obstructed rabbit bladder determined by differential display polymerase chain reaction. J Urol 2001, 165:1289-1293
21. Belichard P, Luccarini JM, Defrene E, Faye P, Franck RM, Duclos H, Paquet JL, Pruneau D: Pharmacological and molecular evidence for kinin B1 receptor expression in urinary bladder of cyclophosphamide-treated rats. Br J Pharmacol 1999, 128:213-219
22. Chopra B, Barrick SR, Meyers S, Beckel JM, Zeidel ML, Ford AP, de Groat WC, Birder LA: Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium. J Physiol 2005, 562:859-871
23. Giglio D, Ryberg AT, To K, Delbro DS, and Tobin G: Altered muscarinic receptor subtype expression and functional responses in cyclophosphamide induced cystitis in rats. Auton Neurosci 2005, 122:9-20
24. Ikeda Y, Birder L, Buffington C, Roppolo J, Kanai A: Mucosal muscarinic receptors enhance bladder activity in cats with feline interstitial cystitis. J Urol 2009, 181:1415-1422
25. Saban MR, Nguyen NB, Hammond TG, Saban R: Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation. Am J Pathol 2002, 160:2095-2110
26. Slobodov G, Feloney M, Gran C, Kyker KD, Hurst RE, Culkin DJ: Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J Urol 2004, 171:1554-1558
27. Hauser PJ, Dozmorov MG, Bane BL, Slobodov G, Culkin DJ, Hurst RE: Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis. J Urol 2008, 179:764-769
28. Zhang CO, Wang JY, Koch KR, Keay S: Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis. J Urol 2005, 174:2382-2387
29. O'Connell RM, Taganov KD, Boldin MP, ChengG, Baltimore D: MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 2007, 104:1604-1609
30. Sonkoly E, Pivarcsi A: Advances in microRNAs: implications for immunity and inflammatory diseases. J Cell Mol Med 2009, 13:24-38
31. Novina CD, Sharp PA: The RNAi revolution. Nature 2004, 430: 161-164
32. Sonkoly E, Stahle M, Pivarcsi A: MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 2008, 18:131-140
33. Moschos SA, Williams AE, Perry MM, Birrell MA, Belvisi MG, Lindsay MA: Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics 2007, 8:240
34. Schafer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, van Kerrebroeck P: Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002, 21:261-274
35. Abrams P, CardozoL, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A: The standardisation of terminology in lower urinary tract function: report from the standardisation subcommittee of the International Continence Society. Urology 2003, 61:37-49
36. Rossi MR, Masters JR, Park S, Todd JH, Garrett SH, Sens MA, Somji S, Nath J, Sens DA: The immortalized UROtsa cell line as a potential cell culture model of human urothelium. Environ Health Perspect 2001, 109:801-808
37. Burkhard FC, Monastyrskaya K, Studer UE, Draeger A: Smooth muscle membrane organization in the normal and dysfunctional human urinary bladder: a structural analysis. Neurourol Urodyn 2005, 24:128-135
38. Monastyrskaya K, Babiychuk EB, Hostettler A, Rescher U, Draeger A: Annexins as intracellular calcium sensors. Cell Calcium 2007, 41: 207-219
39. Griffiths-Jones S: The microRNA Registry. Nucleic Acids Res 2004, 32:D109-D111
40. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ: miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006, 34:D140-D144
41. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ: miRBase: tools for microRNA genomics. Nucleic Acids Res 2008, 36:D154-D158
42. Betel D, Wilson M, Gabow A, Marks DS, Sander C: The microRNA. org resource: targets and expression. Nucleic Acids Res 2008, 36:D149-D153
43. Sturn A, Quackenbush J, Trajanoski Z: Genesis: cluster analysis of microarray data. Bioinformatics 2002, 18:207-208
44. Birder LA, Ruan HZ, Chopra B, Xiang Z, Barrick S, Buffington CA, Roppolo JR, Ford AP, de Groat WC, Burnstock G: Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am J Physiol Renal Physiol 2004, 287:F1084-F1091
45. Tempest HV, Dixon AK, Turner WH, Elneil S, Sellers LA, Ferguson DR: P2X and P2X receptor expression in human bladder urothelium and changes in interstitial cystitis. BJU Int 2004, 93:1344-1348
46. Matschke K, Babiychuk EB, Monastyrskaya K, Draeger A: Phenotypic conversion leads to structural and functional changes of smooth muscle sarcolemma. Exp Cell Res 2006, 312:3495-3503
47. Monastyrskaya K, Hostettler A, Buergi S, Draeger A: The NK1 receptor localizes to the plasma membrane microdomains, and its activation is dependent on lipid raft integrity. J Biol Chem 2005, 280:7135-7146
48. Tsai SJ: Dopamine receptor downregulation: an alternative strategy for schizophrenia treatment. Med Hypotheses 2004, 63:1047-1050
49. Hedley L, Phagoo SB, James IF: Measurement of intracellular calcium in cell populations loaded with aequorin: neurokinin-1 responses in U373MG cells. Anal Biochem 1996, 236:270-274
50. Carthew RW, Sontheimer EJ: Origins and Mechanisms of miRNAs and siRNAs. Cell 2009, 136:642-655
51. Rickard A, Dorokhov N, Ryerse J, Klumpp DJ, McHowat J: Characterization of tight junction proteins in cultured human urothelial cells. In Vitro Cell Dev Biol Anim 2008, 44:261-267
52. Lipschutz JH, Li S, Arisco A, Balkovetz DF: Extracellular signalregulated kinases 1/2 control claudin-2 expression in Madin-Darby canine kidney strain I and II cells. J Biol Chem 2005, 280:3780-3788
53. Yu AS, Cheng MH, Angelow S, Gunzel D, Kanzawa SA, Schneeberger EE, Fromm M, Coalson RD: Molecular basis for cation selectivity in claudin-2-based paracellular pores: identification of an electrostatic interaction site. J Gen Physiol 2009, 133:111-127
54. Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, Malmberg AB, Cain G, Berson A, Kassotakis L: Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 2000, 407:1011-1015
55. Sun Y, Chai TC: Up-regulation of P2X3 receptor during stretch of bladder urothelial cells from patients with interstitial cystitis. J Urol 2004, 171:448-452
56. Sun Y, Chai TC: Augmented extracellular ATP signaling in bladder urothelial cells from patients with interstitial cystitis. Am J Physiol Cell Physiol 2006, 290:C27-C34
57. Gur S, Kadowitz PJ, Hellstrom WJ: Purinergic (P2) receptor control of lower genitourinary tract function and new avenues for drug action: an overview. Curr Pharm Des 2007, 13:3236-3244
58. Sigala S, Mirabella G, Peroni A, Pezzotti G, Simeone C, Spano P, Cunico SC: Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder. Urology 2002, 60:719-725
59. Tyagi V, Philips BJ, Su R, Smaldone MC, Erickson VL, Chancellor MB, Yoshimura N, Tyagi P: Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium. J Urol 2009, 181:1932-1938
60. Bellucci F, Cucchi P, Santicioli P, Lazzeri M, Turini D, Meini S: Characterization of kinin receptors in human cultured detrusor smooth muscle cells. Br J Pharmacol 2007, 150:192-199
61. ter Beek WP, Biemond I, Muller ES, van den BM, Lamers CB: Substance P receptor expression in patients with inflammatory bowel disease. Determination by three different techniques, ie, storage phosphor autoradiography, RT-PCR and immunohistochemistry. Neuropeptides 2007, 41:301-306
62. Bai TR, Zhou D, Weir T, Walker B, Hegele R, Hayashi S, McKay K, Bondy GP, Fong T: Substance P (NK1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway diseases. Am J Physiol: 1995, 269:L309-L317
63. Cottrell GS, Padilla B, Pikios S, Roosterman D, Steinhoff M, Gehringer D, Grady EF, Bunnett NW: Ubiquitin-dependent down-regulation of the neurokinin-1 receptor. J Biol Chem 2006, 281:27773-27783
64. Hedley L, Phagoo SB, James IF: Measurement of intracellular calcium in cell populations loaded with aequorin: neurokinin-1 responses in U373MG cells. Anal Biochem 1996, 236:270-274
65. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F: Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 2007, 25:387-392
66. Ranga K Krishnan R: Clinical experience with substance P receptor (NK1) antagonists in depression. J Clin Psychiatry 2002, 11:25-29
67. Palma C: Tachykinins and their receptors in human malignancies. Curr Drug Target 2006, 7:1043-1052
68. Saluja AK, Steer MLP: Pathophysiology of pancreatitis. Role of cytokines and other mediators of inflammation. Digestion, 60 Suppl 1999, 1:27-33